BIOMAT Database Logo BIOMAT Database Logo

A new bronchodilator, Th 1165a (Berotec). 1972

A S Rebuck, and N A Saunders

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009921 Metaproterenol A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM. Orciprenaline,Alotec,Alupent,Astmopent,Metaprel,Metaproterenol Polistirex,Metaproterenol Sulfate,Orciprenaline Sulfate,Polistirex, Metaproterenol
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D012118 Resorcinols A water-soluble crystalline benzene-1,3-diol (resorcinol) and its derivatives. m-Dihydroxybenzenes,meta-Dihydroxybenzenes,m Dihydroxybenzenes,meta Dihydroxybenzenes
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females

Related Publications

A S Rebuck, and N A Saunders
[Th 1165a (Berotec) in the prevention of bronchospasm induced with pneumoallergens].
January 1975, Archivio Monaldi per la tisiologia e le malattie dell'apparato respiratorio,
A S Rebuck, and N A Saunders
[Clinical study of a new bronchodilator molecule in pediatrics (Th 1165, Fenoterol-Berotec)].
August 1981, Minerva pediatrica,
A S Rebuck, and N A Saunders
Fenoterol hydrobromide (Berotec, Th 1165a) 0.1% solution in the treatment of allergic rhinitis.
February 1980, Annals of allergy,
A S Rebuck, and N A Saunders
The effect of berotec (Th 1165a) on spontaneous and induced uterine activity in the pregnant baboon.
March 1975, American journal of obstetrics and gynecology,
A S Rebuck, and N A Saunders
[A new bronchodilator agent: TH-152].
March 1962, Revista clinica espanola,
A S Rebuck, and N A Saunders
A NEW BRONCHODILATOR DRUG: ALUPENT (TH. 152).
October 1963, The British journal of clinical practice,
A S Rebuck, and N A Saunders
The bronchodilator effect of fenoterol (Berotec).
March 1975, The New Zealand medical journal,
A S Rebuck, and N A Saunders
[Clinical trials with a new bronchodilator: Th 152].
May 1965, Bruxelles medical,
A S Rebuck, and N A Saunders
[Clinical observations on a new bronchodilator: Th-152].
April 1966, Hospital (Rio de Janeiro, Brazil),
A S Rebuck, and N A Saunders
[Comparative studies of the metabolic and cardiovascular effects of 3 current bronchodilator agents (trimethoquinol, terbutaline and Th 1165a)].
December 1977, Minerva pediatrica,
Copied contents to your clipboard!